期刊文献+

芪杉胶囊对肺癌A549细胞PI3KAKt信号通路影响的研究 被引量:2

Effect of Qishan Capsule on PI3KAKt Signaling Pathway in Lung Cancer A549 Cells
下载PDF
导出
摘要 目的:观察芪杉胶囊对肺癌A549细胞PI3KAKt信号通路的影响。方法:分别运用MTT法检测含药血清对A549细胞增殖的影响;Annexin V-PE/7-AAD双染法检测含药血清对A549细胞凋亡的影响;Western-blot法检测含药血清对A549细胞凋亡相关蛋白表达的影响;RT-PCR法检测含药血清对A549细胞凋亡相关基因表达的影响。结果:芪杉胶囊含药血清高、中、低剂量组分别作用于A549细胞时,均表现为抑制细胞增殖作用,其抑制率分别为24.26%,16.44%和10.89%,含药血清浓度越大,对细胞的抑制作用越显著。与空白组相比,芪杉胶囊含药血清高、中、低剂量组及顺铂组细胞凋亡率显著升高,且含药血清浓度越大,对细胞凋亡的作用越显著。芪杉胶囊含药血清高、中、低剂量组及顺铂组Caspase-3、Caspase-9、Cytochrome c、AKT、m TOR及PI3K蛋白和基因相对表达量与空白组相比,表达量降低,且含药血清浓度越大,对A549细胞凋亡相关蛋白和基因表达的影响越显著。结论:芪杉胶囊通过影响A549细胞凋亡相关Caspase-3、Caspase-9、Cytochrome c、AKT、m TOR及PI3K蛋白和基因表达,从而抑制细胞增值、促进细胞凋亡。 Objective: To observe the effect of Qishan Capsule on PI3KAKt signaling pathway in lung cancer A549 cells.Methods: The proliferation and apoptosis of A549 cells intervend with medicated serum were detected by MTT method and Annexin V-PE/7-AAD double staining method respectively. Protein and gene expressions related to apoptosis of A549 cells were tested by Western-blot assay and RT-PCR assay. Results: It is found out that different concentration of serum contaning Qishan Capsule had inhibiting effect on the proliferation of A549 cells; the inhibition rate was 24. 26%,16. 44% and 10. 89%,the higher concentration of the serum was,the more significant inhibitory effect it had on the proliferation of A549 cells. In terms of apoptosis rate,it was significantly increased in serum-Qishan Capsule groups and in cisplatin group,compared to that in the blank control group; the higher concentration of the serum was,the more significant effect it had on apoptosis. In terms of expressions of Caspase-3,Caspase-9,Cytochrome C,AKT,m TOR and PI3K,they were significantly decreased in serum-Qishan Capsule groups and in cisplatin group,compared to those in the blank control group; the higher concentration of the serum was,the more significant decrease was seen on the expressions. Conclusion: Qishan Capsule can inhibit the proliferation and promote apoptosis of A549 cells by regulating the expressions of Caspase-3,Caspase-9,Cytochrome C,AKT,mTOR and PI3 K.
作者 隋雨桐 迟文成 姜家康 SUI Yutong;CHI Wencheng;JIANG Jiakang(The First Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin 150040,China)
出处 《中医药学报》 CAS 2018年第4期22-27,共6页 Acta Chinese Medicine and Pharmacology
基金 黑龙江省自然科学基金面上项目(H201478)
关键词 肺癌 芪杉胶囊 细胞增殖 细胞凋亡 PI3KAKt信号通路 Lung cancer Qishan Capsule Cell proliferation Apoptosis PI3 KAKt signaling pathway
  • 相关文献

参考文献7

二级参考文献101

  • 1廖明娟,陈红风.P13K/Akt/mTOR信号通路抑制剂在乳腺癌中的研究进展[J].中华肿瘤杂志,2012,19(3):230-234.
  • 2Mayo LD, Donner DB. The PTEN, Mdm2, p53 tumor suppres-sor-oncoprotein network[J]. Trends Biochem Sci, 2002, 27(9): 462-467.
  • 3Mazzoletti M, Broggini M. PI3K/ AKT/mTOR inhihitors in o-varian cancer[J]. Curr Med Chern, 2010, 17(36) :4433-4447.
  • 4Almhanna K, Strosberg J, Malafa M. Targeting AKT protein kinase in gastric cancer [J]. Anticancer Res, 2011, 31 ( 12) : 4387-4392.
  • 5Cinti C, Vindigni C, Zamparelli A, et al. Activated Akt as an indicator of prognosis in gastric cancer [J]. Virchows Arch, 2008,453(5) :449-455.
  • 6Verhaegh ME, Sanders CJ, Arends JW, et al. Expression of the poptosis-suppressing protein Bcl-2 in non-melanoma skin cancer [J]. Br J Derrnatol , 1995, 132(5) :740-744.
  • 7Morales-Ducret CR, van de Rijn M, Lebrun DP, et al. Bcl-2 ex-pression in primary malignancies of the skin[J]. Arch Derrnatol , 1995, 131 (8): 909-912.
  • 8Roper J, Richardson MP, Wanq WV, et al. The dual PI3 KI mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild-type colorectal cancer [J]. PLoS ONE, 2011,6(9) : e25132.
  • 9Amado R G, Wolf M, Peeters M, et at. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J]. J Clin Oncol , 2008, 26(10): 1626-1634.
  • 10Bokemeyer C, Kohne C, Rougier P, et at. Cetuximab with chemotherapy ( CT) as first-line treatment for metastatic colorectal cancer (mCRC) : Analysis of the CRYSTAL and OPUS studies according to KRAS and BRAF mutation status [J]. J Clin Oncol , 2010, 28 (15): abstr 3506.

共引文献99

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部